WO2007079181A3 - Methods and systems for recommending an action to a patient for managing epilepsy and other neurological disorders - Google Patents

Methods and systems for recommending an action to a patient for managing epilepsy and other neurological disorders Download PDF

Info

Publication number
WO2007079181A3
WO2007079181A3 PCT/US2006/049486 US2006049486W WO2007079181A3 WO 2007079181 A3 WO2007079181 A3 WO 2007079181A3 US 2006049486 W US2006049486 W US 2006049486W WO 2007079181 A3 WO2007079181 A3 WO 2007079181A3
Authority
WO
WIPO (PCT)
Prior art keywords
patient
neurological disorders
action
recommending
systems
Prior art date
Application number
PCT/US2006/049486
Other languages
French (fr)
Other versions
WO2007079181A2 (en
Inventor
Kent W Leyde
Daniel J Dilorenzo
Original Assignee
Neurovista Corp
Kent W Leyde
Daniel J Dilorenzo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/321,897 external-priority patent/US8868172B2/en
Priority claimed from US11/321,898 external-priority patent/US8725243B2/en
Application filed by Neurovista Corp, Kent W Leyde, Daniel J Dilorenzo filed Critical Neurovista Corp
Priority to EP06848279A priority Critical patent/EP1971394A4/en
Publication of WO2007079181A2 publication Critical patent/WO2007079181A2/en
Publication of WO2007079181A3 publication Critical patent/WO2007079181A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
    • A61B5/4094—Diagnosing or monitoring seizure diseases, e.g. epilepsy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A61B5/369—Electroencephalography [EEG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A61N1/36082—Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235—Details of waveform analysis
    • A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Physiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Developmental Disabilities (AREA)
  • Hospice & Palliative Care (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)

Abstract

The present invention provides methods and system for managing neurological disorders, such as epilepsy. In one embodiment, the method comprises measuring one or more signals from a patient and processing the one or more signals to characterize a patient's propensity for a future seizure. The characterized propensity for the seizure is thereafter used to determine an appropriate action for managing or treating the predicted seizure; and a recommendation is communicated to the patient that is indicative of the appropriate action.
PCT/US2006/049486 2005-12-28 2006-12-28 Methods and systems for recommending an action to a patient for managing epilepsy and other neurological disorders WO2007079181A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP06848279A EP1971394A4 (en) 2005-12-28 2006-12-28 Methods and systems for recommending an action to a patient for managing epilepsy and other neurological disorders

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11/321,897 US8868172B2 (en) 2005-12-28 2005-12-28 Methods and systems for recommending an appropriate action to a patient for managing epilepsy and other neurological disorders
US11/321,898 2005-12-28
US11/321,897 2005-12-28
US11/321,898 US8725243B2 (en) 2005-12-28 2005-12-28 Methods and systems for recommending an appropriate pharmacological treatment to a patient for managing epilepsy and other neurological disorders

Publications (2)

Publication Number Publication Date
WO2007079181A2 WO2007079181A2 (en) 2007-07-12
WO2007079181A3 true WO2007079181A3 (en) 2008-06-12

Family

ID=38228852

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/049486 WO2007079181A2 (en) 2005-12-28 2006-12-28 Methods and systems for recommending an action to a patient for managing epilepsy and other neurological disorders

Country Status (2)

Country Link
EP (1) EP1971394A4 (en)
WO (1) WO2007079181A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010049547A1 (en) * 2008-10-31 2010-05-06 Fundació Institut Guttmann Method and system to safely guide interventions in procedures the substrate whereof is neuronal plasticity
DE102008043973B4 (en) * 2008-11-21 2011-12-01 Burkhard Brocke Device for transcranial neurostimulation
EP2369986A4 (en) * 2008-12-23 2013-08-28 Neurovista Corp Brain state analysis based on select seizure onset characteristics and clinical manifestations
US8543422B2 (en) * 2011-04-04 2013-09-24 International Business Machines Corporation Personalized medical content recommendation
DK177536B1 (en) 2011-07-19 2013-09-16 Ictalcare As Method for detecting seizures
BR112015008222A2 (en) 2012-10-12 2017-07-04 Massachusetts Gen Hospital system and method for monitoring and controlling a patient's condition during and after administration of an anesthetic compound
KR102245345B1 (en) 2014-09-29 2021-04-28 조게닉스 인터내셔널 리미티드 Control system for control of distribution of medication
EP3393470B1 (en) 2015-12-22 2021-01-20 Zogenix International Limited Metabolism resistant fenfluramine analogs and methods of using the same
KR20180091924A (en) 2015-12-22 2018-08-16 조게닉스 인터내셔널 리미티드 Fenfluramine composition and method for its preparation
CN109689103A (en) 2016-08-24 2019-04-26 周格尼克斯国际有限公司 For inhibiting 5-HT2BThe preparation and its application method of the formation of agonist
US11612574B2 (en) 2020-07-17 2023-03-28 Zogenix International Limited Method of treating patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
CN114010207B (en) * 2022-01-10 2022-04-29 博睿康科技（常州）股份有限公司 Time domain data classification method based on zero crossing coefficient and implantable stimulation system

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020002390A1 (en) * 1997-10-27 2002-01-03 Fischell Robert E. Implantable neurostimulator having a data communication link
US20040176359A1 (en) * 2001-02-20 2004-09-09 University Of Kentucky Research Foundation Intranasal Benzodiazepine compositions
US20050209218A1 (en) * 2004-02-13 2005-09-22 Meyerson Laurence R Methods and compositions for the treatment of psychiatric conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5995868A (en) * 1996-01-23 1999-11-30 University Of Kansas System for the prediction, rapid detection, warning, prevention, or control of changes in activity states in the brain of a subject
US6970742B2 (en) * 2000-01-11 2005-11-29 Savacor, Inc. Method for detecting, diagnosing, and treating cardiovascular disease
US6594524B2 (en) * 2000-12-12 2003-07-15 The Trustees Of The University Of Pennsylvania Adaptive method and apparatus for forecasting and controlling neurological disturbances under a multi-level control
US6810285B2 (en) * 2001-06-28 2004-10-26 Neuropace, Inc. Seizure sensing and detection using an implantable device

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020002390A1 (en) * 1997-10-27 2002-01-03 Fischell Robert E. Implantable neurostimulator having a data communication link
US20040176359A1 (en) * 2001-02-20 2004-09-09 University Of Kentucky Research Foundation Intranasal Benzodiazepine compositions
US20050209218A1 (en) * 2004-02-13 2005-09-22 Meyerson Laurence R Methods and compositions for the treatment of psychiatric conditions

Also Published As

Publication number Publication date
EP1971394A2 (en) 2008-09-24
WO2007079181A2 (en) 2007-07-12
EP1971394A4 (en) 2009-04-01

Similar Documents

Publication Publication Date Title
WO2007079181A3 (en) Methods and systems for recommending an action to a patient for managing epilepsy and other neurological disorders
WO2008017055A3 (en) Methods for treating neurological disorders, including neuropsychiatric and neuropsychological disorders, and associated systems
WO2007079191A3 (en) System for characterizing a patient's propensity for a neurological event
ATE444016T1 (en) METHOD AND DEVICE FOR DETECTING DISORDERS OF THE NERVOUS SYSTEM
WO2007124194A3 (en) Method and apparatus for detection of nervous system disorders
MX2007010064A (en) System and method of prediction of response to neurological treatment using the electroencephalogram.
WO2008092119A3 (en) Systems and methods for identifying a contra-ictal condition in a subject
WO2004023983A3 (en) Noninvasive nonlinear systems and methods for predicting seizure
SG10201407388XA (en) Humanized anti-cxcr5 antibodies, derivatives thereof and their uses
WO2006113804A3 (en) Systems and methods for non-invasive physiological monitoring of non-human animals
WO2007123723A3 (en) Diagnosis and treatment of alzheimer's disease
EA200600920A1 (en) IMMUNESORBENT STUDIES OF THE BLOOD FOR THE ESTIMATION OF PAROXISMAL CEREBRAL BULBS
WO2007118029A3 (en) Methods and systems for assessing and improving the performance of a speech recognition system
WO2009041501A1 (en) Factor involved in latent infection with herpesvirus, and use thereof
WO2001078704A3 (en) Gaba substrate and the use thereof for treating cognitive and emotional disorders
BRPI0508084A (en) method for the treatment of a neurological disorder, and use of meridamycin or a salt thereof
WO2002063005A3 (en) Lipid-associated molecules
WO2006080549A3 (en) Method and composition for treating central nervous system disorders
SG11201906715WA (en) Activated rice husk filters, filter media, and methods
WO2002046384A3 (en) Kinases and phosphatases sequences, and use thereof
WO2004070025A3 (en) Novel goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders
WO2002004678A3 (en) Methods and compositions for diagnosing and treating preeclampsia and gestational trophoblast disorders
WO2007067263A3 (en) Diagnostic methods for pain sensitivity and chronicity and for tetrahydrobiopterin-related disorders
WO2007127237A3 (en) Methods of diagnosing and treating migraine
WO2001053468A3 (en) Lipid metabolism enzymes and polynucleotides encoding them

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2006848279

Country of ref document: EP